Warburg Pincus Private Equity X, L.P. Insider Trading $CBPO China Biologic Products Holdings, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Warburg Pincus Private Equity X, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Warburg Pincus Private Equity X, L.P.. Warburg Pincus Private Equity X, L.P. is 10% Owner in MBIA INC ($MBI) and Director in Endurance International Group Holdings, Inc. ($EIGI) and 10% Owner in China Biologic Products, Inc. ($CBPO) and Director in China Biologic Products, Inc. ($CBPO) and Director in ANTERO RESOURCES Corp ($AR) and Director in Financial Engines, Inc. ($FNGN) and Director in CrowdStrike Holdings, Inc. ($CRWD).
Warburg Pincus Private Equity X, L.P. in China Biologic Products Holdings, Inc.
Trading Symbol: CBPOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Warburg Pincus Private Equity X, L.P.: Director, 10% Owner
Holdings: 7,876,280 shares
Current Value: $896,556,952
Latest Transaction: Jun 05 2012
$CBPO Market Capitalization: $3.08B
$CBPO Previous Close: $113.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Warburg Pincus Private Equity X, L.P. in China Biologic Products Holdings, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AR, CBPO, CRWD, EIGI, FNGN, MBI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2012 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 12.50 | 1,608,363 | 20,104,538 | 7,876,280 | 6.3 M to 7.9 M (+25.66 %) |
Dec 19 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.44 | 253,236 | 2,895,931 | 6,267,917 | 6 M to 6.3 M (+4.21 %) |
Dec 14 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.65 | 31,904 | 371,570 | 5,761,220 | 5.7 M to 5.8 M (+0.56 %) |
Dec 14 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.28 | 47,461 | 535,241 | 5,729,316 | 5.7 M to 5.7 M (+0.84 %) |
Dec 16 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.33 | 216,146 | 2,447,940 | 6,014,681 | 5.8 M to 6 M (+3.73 %) |
Dec 16 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.59 | 37,315 | 432,488 | 5,798,535 | 5.8 M to 5.8 M (+0.65 %) |
Dec 12 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.53 | 49,600 | 572,012 | 5,681,855 | 5.6 M to 5.7 M (+0.88 %) |
Dec 09 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.01 | 32,723 | 360,130 | 5,632,255 | 5.6 M to 5.6 M (+0.58 %) |
Dec 09 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 10.51 | 25,066 | 263,361 | 5,599,532 | 5.6 M to 5.6 M (+0.45 %) |
Dec 07 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 10.10 | 94,210 | 951,860 | 5,574,466 | 5.5 M to 5.6 M (+1.72 %) |
Dec 07 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 9.62 | 6,630 | 63,781 | 5,480,256 | 5.5 M to 5.5 M (+0.12 %) |
Dec 01 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 7.78 | 15,267 | 118,808 | 5,465,745 | 5.5 M to 5.5 M (+0.28 %) |
Dec 01 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 7.33 | 28,421 | 208,414 | 5,450,478 | 5.4 M to 5.5 M (+0.52 %) |
Dec 05 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 9.43 | 1,748 | 16,492 | 5,473,626 | 5.5 M to 5.5 M (+0.03 %) |
Dec 05 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 8.58 | 6,133 | 52,639 | 5,471,878 | 5.5 M to 5.5 M (+0.11 %) |
May 31 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 16.14 | 109,721 | 1,770,875 | 5,422,057 | 5.3 M to 5.4 M (+2.07 %) |
May 31 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 16.26 | 97,440 | 1,584,111 | 5,312,336 | 5.2 M to 5.3 M (+1.87 %) |
May 26 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 15.41 | 35,362 | 544,776 | 5,214,896 | 5.2 M to 5.2 M (+0.68 %) |
May 26 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 15.15 | 257,114 | 3,896,408 | 5,179,534 | 4.9 M to 5.2 M (+5.22 %) |
May 24 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 14.82 | 14,869 | 220,290 | 4,922,420 | 4.9 M to 4.9 M (+0.30 %) |
May 24 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 14.91 | 20,030 | 298,629 | 4,907,551 | 4.9 M to 4.9 M (+0.41 %) |
May 20 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 14.66 | 28,751 | 421,380 | 4,887,521 | 4.9 M to 4.9 M (+0.59 %) |
May 20 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 14.21 | 38,770 | 550,798 | 4,858,770 | 4.8 M to 4.9 M (+0.80 %) |
Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 17.35 | 8,265 | 143,398 | 4,820,000 | 4.8 M to 4.8 M (+0.17 %) |
Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 16.64 | 91,735 | 1,526,012 | 4,811,735 | 4.7 M to 4.8 M (+1.94 %) |
Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 16.54 | 9,000 | 148,829 | 4,720,000 | 4.7 M to 4.7 M (+0.19 %) |
Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 15.83 | 41,000 | 648,895 | 4,711,000 | 4.7 M to 4.7 M (+0.88 %) |
Page: 1